[Certain biological properties of mutant human tumor necrosis factor-alpha].
Sandakhchiev
L S
LS
Merzlikin
N V
NV
Pustoshilova
N M
NM
Istomina
N N
NN
Lebedev
L R
LR
Sviatchenko
M I
MI
Danilenko
E D
ED
Masycheva
V I
VI
Usova
S V
SV
D019943:Amino Acid Substitution; D000818:Animals; D000970:Antineoplastic Agents / Q000493:pharmacokinetics / Q000494:pharmacology*; D001120:Arginine / Q000235:genetics; D004354:Drug Screening Assays, Antitumor; D004355:Drug Stability; D006801:Humans; D007822:Laryngeal Neoplasms / Q000473:pathology; D007948:Leukemia, Monocytic, Acute / Q000473:pathology; D051379:Mice; D011817:Rabbits; D011994:Recombinant Proteins / Q000235:genetics / Q000493:pharmacokinetics / Q000494:pharmacology; D014407:Tumor Cells, Cultured; D014409:Tumor Necrosis Factor-alpha / Q000235:genetics / Q000493:pharmacokinetics / Q000494:pharmacology*
D000970:Antineoplastic Agents; D011994:Recombinant Proteins; D014409:Tumor Necrosis Factor-alpha; D001120:Arginine
Nekotorye biologicheskie svoĭstva mutantnogo faktora nekroza opukholi-al'fa cheloveka.